Jmm Formulation Profile
Key Indicators
- Authorised Capital ₹ 4.15 Cr
as on 11-12-2024
- Paid Up Capital ₹ 1.94 Cr
as on 11-12-2024
- Company Age 8 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 16.45 Cr
as on 11-12-2024
- Revenue 120.66%
(FY 2022)
- Profit 52.97%
(FY 2022)
- Ebitda 47.22%
(FY 2022)
- Net Worth -13.94%
(FY 2022)
- Total Assets 13.28%
(FY 2022)
About Jmm Formulation
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.15 Cr and a paid-up capital of Rs 1.94 Cr.
The company currently has active open charges totaling ₹16.45 Cr.
Sushil Kumar, Shiv Charan, Peer Chand, and One other member serve as directors at the Company.
- CIN/LLPIN
U51909HP2016PTC006427
- Company No.
006427
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Dec 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- Location
Sirmaur, Himachal Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Jmm Formulation Private Limited offer?
Jmm Formulation Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Medicine.
Who are the key members and board of directors at Jmm Formulation?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sushil Kumar  | Director | 22-Dec-2016 | Current |
| Shiv Charan | Director | 22-Dec-2016 | Current |
| Peer Chand | Director | 22-Dec-2016 | Current |
| Madan Lal | Director | 10-May-2018 | Current |
Financial Performance of Jmm Formulation.
Jmm Formulation Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 120.66% increase. The company also saw a substantial improvement in profitability, with a 52.97% increase in profit. The company's net worth observed a substantial decline by a decrease of 13.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jmm Formulation?
Unlock access to Jmm Formulation's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Ganauli Baghwani Producer Company LimitedActive 5 years 10 monthsShiv Charan and Madan Lal are mutual person
Charges (Loans)
₹16.45 Cr
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 11.95 Cr
- Others : 4.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Sep 2023 | Axis Bank Limited | ₹2.20 Cr | Open |
| 05 Sep 2023 | Axis Bank Limited | ₹3.80 Cr | Open |
| 03 Mar 2022 | Axis Bank Limited | ₹1.00 Cr | Open |
| 08 Feb 2022 | Axis Bank Limited | ₹3.15 Cr | Open |
| 27 Dec 2021 | Axis Bank Limited | ₹1.80 Cr | Open |
How Many Employees Work at Jmm Formulation?
Unlock and access historical data on people associated with Jmm Formulation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jmm Formulation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jmm Formulation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.